Liarakos, Alexandros L. http://orcid.org/0000-0003-1713-3064
Lim, Jonathan Z. M. http://orcid.org/0000-0003-3682-8910
Leelarathna, Lalantha http://orcid.org/0000-0001-9602-1962
Wilmot, Emma G. http://orcid.org/0000-0002-8698-6207
Article History
Received: 5 March 2024
Accepted: 9 May 2024
First Online: 29 June 2024
Funding
: This review received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.
: ALL has received support to attend conferences from Eli Lilly and Novo Nordisk and research support from the Association of British Clinical Diabetologists. LL has received research support from Abbott Diabetes Care and Dexcom, participated in advisory groups for Abbott Diabetes Care, Insulet, Dexcom, Medtronic and Roche Diabetes, and received fees for speaking from Sanofi, Insulet, Medtronic and Abbott. EGW has received personal fees from Abbott, AstraZeneca, Dexcom, Eli Lilly, Embecta, Glooko, Insulet, Medtronic, Novo Nordisk, Roche, Sanofi, Sinocare and Ypsomed, research support from the Association of British Clinical Diabetologists, Abbott, Diabetes UK, Embecta, Insulet, Novo Nordisk and Sanofi, and medical writing support from Abbott, Eli Lilly and Embecta, and has participated in consultancy/been an advisory board member for Abbott, Dexcom, Eli Lilly, Embecta, Insulet, Medtronic, Novo Nordisk, Roche and Sanofi. JZML declares that there are no relationships or activities that might bias, or be perceived to bias, this work.
: All authors were responsible for drafting the article and reviewing it critically for important intellectual content. All authors approved the version to be published.